SCHEMBL23219007

SCHEMBL23219007

CCOC(=O)Cc1ccccc1OCc1nn(C(C)C)c2ccc(-c3ccc(N)cc3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFD P00746 4/20 0.47
TBXAS1 P24557 1/20 0.40
F11 P03951 3/20 0.35
TPSB2 P20231 2/20 0.35
ICMT O60725 4/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
AHR P35869 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
DPP4 P27487 2/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
DHFR P00374 2/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852422 1.00 CFD (0.47) CFDTBXAS1F11TPSB2ICMT
SCHEMBL29122273 0.93 CFD (0.46) CFDTBXAS1F11TPSB2ICMT
SCHEMBL29852706 0.93 CFD (0.49) CFDTBXAS1F11TPSB2ICMT
SCHEMBL23218752 0.93 CFD (0.49) CFDTBXAS1F11TPSB2ICMT
SCHEMBL23219207 0.92 CFD (0.55) CFDTBXAS1F11TPSB2ICMT
SCHEMBL29852913 0.92 CFD (0.55) CFDTBXAS1F11TPSB2ICMT
SCHEMBL29340041 0.90 CFD (0.46) CFDTBXAS1F11TPSB2ICMT
SCHEMBL23218754 0.89 CFD (0.46) CFDF11TPSB2ICMTPOLB
SCHEMBL29592077 0.89 CFD (0.46) CFDF11TPSB2ICMTPOLB
SCHEMBL29122667 0.89 CFD (0.44) CFDTBXAS1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed